Zobrazeno 91 - 100
of 26 743
pro vyhledávání: ''
Autor:
Yasuhiko Ito, Hirokazu Sugiyama, Satoru Ito, Akihito Kubo, Shiho Iwagaitsu, Takayuki Katsuno, Hiroshi Kinashi, Hironobu Nobata, Makoto Yamaguchi, Shogo Banno, Etsuro Yamaguchi
Publikováno v:
Modern Rheumatology Case Reports. 6:1-5
A 53-year-old woman diagnosed with rheumatoid arthritis (RA) demonstrated thick-walled large cavities with consolidation in the left upper lobe on chest computed tomography (CT). Mycobacterium avium was isolated from sputum cultures, and she was diag
Autor:
Mario Štefanović, Nora Nikolac Gabaj, Lovorka Đerek, Marijana Miler, Vedran Tomašić, Joško Mitrović, Alen Bišćanin, Nada Vrkić, Jadranka Morović-Vergles, Simeon Grazio, Ivana Ćelap
Publikováno v:
Rheumatology International. 41:2195-2203
The hypothesis of the study was that polymorphisms in promoter regions -238 and -308 of TNF-α could be associated with different clinical outcomes in inflammatory bowel diseases (IBD) and immune- mediated rheumatic diseases (IMRD). The aim was to ex
Publikováno v:
International Journal of Research and Review. 8:28-32
Background/aim: Bacterial meningitis is inflammation of the lining of the brain due to bacterial invasion of the CNS, especially in the cerebrospinal fluid in the subarachnoid and ventricles. Transmission of S. suis to humans occurs through direct co
Autor:
Arvind Kumar, Rajeev Kumar, S. K. Kabra, Kana Ram Jat, Jyoti Kumari, Rajesh Kumar, Ashu Seith Bhalla, Karan Aggarwal
Publikováno v:
Indian Journal of Otolaryngology and Head & Neck Surgery. 74:5117-5121
Vascular Endothelial Growth Factor has been demonstrated in squamous papillomas of Recurrent Respiratory Papillomatosis patients. This case series aimed at studying the feasibility and efficacy of systemic use of VEGF inhibitor Bevacizumab in advance
Autor:
Sven Heldt, Guangyu Shao, Christian Paar, Markus Winkler, Gamze Demireli, Karoline Ornig, Michael Mandl, Helmut J. F. Salzer, Bernd Lamprecht, Matthias Neuböck, Bakari Chitechi
Publikováno v:
Wiener Medizinische Wochenschrift. 172:268-273
Summary Background Gastrointestinal tuberculosis (TB) is a rare manifestation in low TB-incidence countries such as Austria. It is usually seen in immunocompromised patients or in migrants being more susceptible for extrapulmonary disease manifestati
Publikováno v:
The EYE GLAZ. 23:19-26
Background. The causative agent of the coronavirus infection – SARS-CoV-2 – remains active and causes new cases despite the measures taken around the world. In order to timely detect ophthalmopathies in patients with dyslipidemia who have gone th
Publikováno v:
Probiotics and Antimicrobial Proteins. 15:379-386
In the present double-blind randomised study, the efficacy of combination of Bacillus coagulans Unique IS2 and lactulose was evaluated in the treatment of functional constipation in adults. One-fifty participants diagnosed with functional constipatio
Publikováno v:
Infection and Drug Resistance
Shota Kashiwagura,1 Yasuhiro Kamioka,1 Masafumi Seki,2 Satoshi Koshika,1 Kouji Okada1,3 1Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi, Japan; 2Division of Infectious Diseases and Infection Control
Autor:
Kazuo Eguchi, Naoki Arakawa, Yuta Tsukahara, Youhei Koushima, Hidekazu Matsushima, Yuki Nakamura
Publikováno v:
Internal Medicine
A 94-year-old woman with rheumatoid arthritis who had been treated with low-dose methotrexate was referred to our hospital because of a 3-day history of a fever and pancytopenia. With a diagnosis of febrile neutropenia of unknown origin, empirical an
Autor:
Robert Peric, Vincent van der Noort, Harry J.M. Groen, Anne-Marie C. Dingemans, Nico van Walree, Franz M.N.H. Schramel, Christi M.J. Steendam, Pepijn Brocken, Stijn L.W. Koolen, G.D. Marijn Veerman, John W. G. van Putten, Ron H.J. Mathijssen, Egbert F. Smit, Joachim G.J.V. Aerts, Magdolen Youssef
Publikováno v:
Lung Cancer, 160, 44-49. Elsevier Ireland Ltd
Lung Cancer, 160, 44-49. ELSEVIER IRELAND LTD
Lung Cancer, 160, 44-49. ELSEVIER IRELAND LTD
Background: Earlier preclinical and phase II research showed enhanced effect of docetaxel plus intercalated erlotinib. The NVALT-18 phase III study was designed to compare docetaxel with docetaxel plus intercalated erlotinib in relapsed metastasized